Secretory IgA Test · Stool

Most of your immune system actually lives in your gut, and most of the antibodies it makes end up in one place: the thin layer of mucus coating your intestines. Measuring that antibody in stool gives you a window into how well your gut is defending itself against the trillions of microbes living inside you.

Stool sIgA (secretory immunoglobulin A) is a research-oriented marker of that defense. It is not a standardized clinical test with universal cutoffs, but it can flag whether your mucosal barrier is intact, overworked, or compromised, especially when paired with other gut markers.

What This Antibody Actually Does

sIgA is a paired antibody molecule built to survive in the harsh, enzyme-rich environment of your gut. Immune cells sitting just beneath your intestinal lining produce it, and a transport protein ferries it through the gut wall and anchors a protective sleeve onto it that resists digestion.

Once in the gut, sIgA binds to bacteria, viruses, toxins, and food proteins. This coating, sometimes called immune exclusion, stops them from attaching to your gut wall or slipping across it into your bloodstream. It also helps shape which microbes are allowed to thrive in your gut, a process researchers describe as antibody-mediated immune selection.

Why Gut Barrier Function Matters

When stool sIgA is very low or absent, the gut's first line of defense is weakened. Research in people with IgA deficiency shows that this destabilizes the balance between you and your microbes, leading to increased bacterial translocation, more systemic antibodies aimed at gut microbes, higher inflammatory cytokines (immune signaling proteins), and broader T-cell activation.

People who lack both serum and fecal sIgA tend to have more infections, more atopic and autoimmune disease, and signs of low-grade systemic immune dysregulation. Mucosal IgA is described in the literature as a pillar of the gut barrier, and losing it has consequences that reach far beyond digestion.

Immune Dysregulation and Autoimmunity

Gut sIgA does more than block germs. It helps your immune system tolerate the friendly bacteria and food particles you encounter every day. When that tolerance breaks down, systemic immune activation goes up.

Observational evidence links deficient mucosal IgA to inflammatory bowel disease, food allergy, and Helicobacter-associated gastritis. Lack of gut sIgA in people with memory B-cell dysfunction, such as those with asplenia (absent or non-functioning spleen) or common variable immunodeficiency, is tied to increased bacterial translocation and compromised mucosal protection.

When High sIgA Is Not Automatically Good

It is tempting to assume that more sIgA always means stronger defense. The evidence is more nuanced. A very high reading can reflect active mucosal inflammation, immune activation against an infection, or an overworked barrier responding to ongoing stress from the gut contents.

This marker is not a simple higher-is-better or lower-is-better number. It is a phenotype signal, meaning it reflects the overall state of your gut immune system rather than a single dial to turn up or down. A low level suggests weakened defense. A very high level suggests the system is ramped up for a reason. In both cases, the sIgA reading gains meaning only when you look at the context, including other gut markers and your symptoms.

Reference Ranges

There is no universally agreed clinical cutoff for stool sIgA. Assays vary widely between labs, and published research values are drawn from small cohorts rather than large population surveys. The ranges below are illustrative orientation, not clinical targets. Your lab will likely report its own analytical reference interval, possibly in different units.

Compare your results within the same lab over time for the most meaningful trend. A number that is high or low in one lab's assay may not map directly onto another lab's cutoffs.

Tracking Your Trend

Because stool sIgA varies with diet, stress, infection, and the day-to-day state of your gut, a single reading is rarely enough to act on. Salivary sIgA (a related but different measurement) can vary substantially within the same person across short time windows, and gut sIgA is likely similarly dynamic.

Get a baseline, retest in 3 to 6 months if you are making meaningful changes to your diet, gut care, or immune health, and track at least annually if you have ongoing symptoms. The trajectory matters more than any single value. A steady low trend alongside gut symptoms is more actionable than one low reading in isolation.

When Results Can Be Misleading

A single stool sample can be thrown off by several factors that have nothing to do with your actual mucosal immune status:

• Recent acute illness: a gastrointestinal infection or cold in the prior weeks can transiently push sIgA up as your gut mounts a local response.
• Sample variability: sIgA is not evenly distributed through stool, and day-to-day variability is substantial. One low or high reading is not a diagnosis.
• Collection handling: delays in sample processing, freeze-thaw cycles, and differences in assay method between labs can meaningfully change the reported number.
• Recent intense exercise or acute stress: these have been shown to shift mucosal sIgA at other sites like saliva, and similar short-term effects on gut sIgA are plausible.

What to Do With an Abnormal Result

Treat this marker as one piece of a larger gut picture, not a standalone verdict. If your result is very low and you have recurrent infections, chronic digestive symptoms, or a family history of immune deficiency, a workup for selective IgA deficiency (measuring serum IgA and total immunoglobulins) is a reasonable next step with a primary care clinician or immunologist.

If your result is high, pair it with markers of gut inflammation like calprotectin, pancreatic elastase, and a stool pathogen screen. A high sIgA alongside elevated calprotectin points toward active gut inflammation worth investigating. A high sIgA alongside detectable pathogens points toward an active immune response to that specific exposure. In both cases, retesting after addressing the underlying trigger is more informative than chasing the single number.